Embracing consumerism: Driving customer engagement in the healthcare financial journey

whitePaper | December 27, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way. Regulatory agencies prioritize patient safety in this highly regulated industry.

whitePaper | October 12, 2022

The configurability options of a deep digital health white label span from how you accept patients, to how you coordinate care, to how you treat specific medical conditions. This is difficult to achieve with a static solution with fixed capabilities.

whitePaper | June 7, 2022

In a recent webinar, Dawn Crump, Senior Director of Revenue Cycle Solutions at the Norristown, Pennsylvania-based MRO Corporation, shared her expertise with her virtual audience, around the very important topic of payment integrity audits.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | November 24, 2022

It is no secret that physicians, nurses, and other health care professionals have long been subject to grueling schedules and demands that can take a toll on their well-being.

whitePaper | June 3, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.